Herclon 440 Mg is a prescription drug for treatment of breast cancer. It is manufactured in USA and marketed by Roche. It is popularly known as ‘Herceptin‘ in Europe & America. The generic name for the medicine is Trastuzumab.

Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature.* Herceptin can be used in several different ways:

As part of a treatment course including the chemotherapy drugs Adriamycin® (doxorubicin), Cytoxan® (cyclophosphamide), and either Taxol® (paclitaxel) or Taxotere® (docetaxel). This treatment course is known as “AC→TH.”

With the chemotherapy drugs Taxotere and Paraplatin® (carboplatin). This treatment course is known as “TCH.”

Alone after treatment with multiple other therapies, including an anthracycline (Adriamycin)-based therapy (a type of chemotherapy).

People reacts to medications differently, A person may suffer from a rash while taking a certain medication, yet another person on a similar drug may have no reaction what so ever. All medications and Herclon included might have a potential to cause drug reaction, Yet only about 10% of reactions to drugs are allergic. Allergic or not, drug reactions can vary from subtle to life-threatening.Take all your medications exactly as your physician prescribed it and guided your.If you suspect a drug allergy has occurred, Contact your physician as soon as possible. In case of severe symptoms seek medical help at once.

Herceptin can cause serious heart problems, including:

• A decline in heart function
• Irregular heartbeats
• High blood pressure
• Serious heart attack
• Death